Francesco Caso
Cited by
Cited by
Overlap connective tissue disease syndromes
L Iaccarino, M Gatto, S Bettio, F Caso, M Rampudda, M Zen, A Ghirardello, ...
Autoimmunity Reviews 12 (3), 363-373, 2013
Blau syndrome, clinical and genetic aspects
P Sfriso, F Caso, S Tognon, P Galozzi, A Gava, L Punzi
Autoimmunity reviews 12 (1), 44-51, 2012
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study
L Costa, F Caso, L D’Elia, M Atteno, R Peluso, A Del Puente, P Strazzullo, ...
Clinical rheumatology 31 (4), 711-715, 2012
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous diseaseá…
M Atteno, R Peluso, L Costa, S Padula, S Iervolino, F Caso, A Sanduzzi, ...
Clinical rheumatology 29 (4), 399-403, 2010
Anakinra treatment in drug-resistant Behcet’s disease: a case series
L Cantarini, A Vitale, P Scalini, CA Dinarello, D Rigante, R Franceschini, ...
Clinical Rheumatology 34 (7), 1293-1301, 2015
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues
F Caso, D Rigante, A Vitale, OM Lucherini, L Costa, M Atteno, ...
International Journal of Rheumatology 2013, 2013
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behšet's disease
L Cantarini, G Lopalco, F Caso, L Costa, F Iannone, G Lapadula, ...
Autoimmunity Reviews 14 (1), 1-9, 2015
Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients
L Costa, F Caso, M Atteno, A Del Puente, MA Darda, P Caso, A Ortolan, ...
Clinical rheumatology 33 (6), 833-839, 2014
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders
A Vitale, D Rigante, OM Lucherini, F Caso, I Muscari, F Magnotti, MG Brizi, ...
Mediators of Inflammation 2013, 2013
Diagnosis and classification of relapsing polychondritis
L Cantarini, A Vitale, MG Brizi, F Caso, B Frediani, L Punzi, M Galeazzi, ...
Journal of autoimmunity 48, 53-59, 2014
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease
F Caso, P Galozzi, L Costa, P Sfriso, L Cantarini, L Punzi
RMD open 1 (1), 2015
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis
F Caso, L Costa, D Rigante, A Vitale, R Cimaz, OM Lucherini, P Sfriso, ...
Autoimmunity Reviews 13 (12), 1220-1229, 2014
Biological treatments in Behšet’s disease: beyond anti-TNF therapy
F Caso, L Costa, D Rigante, OM Lucherini, P Caso, V Bascherini, ...
Mediators of inflammation 2014, 2014
Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients
L Costa, F Caso, M Atteno, C Giannitti, A Spadaro, R Ramonda, M Vezz¨, ...
Clinical rheumatology 33 (2), 273-276, 2014
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up
L Cantarini, D Rigante, G Merlini, A Vitale, F Caso, OM Lucherini, P Sfriso, ...
Seminars in Arthritis and Rheumatism 43 (6), 818-823, 2014
Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behcet's disease: a case series
A Vitale, D Rigante, F Caso, MG Brizi, M Galeazzi, L Costa, ...
Dermatology 228 (3), 211-214, 2014
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice
M Fabbroni, L Cantarini, F Caso, L Costa, VA Pagano, B Frediani, ...
Mediators of inflammation 2014, 2014
Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study
L Costa, F Caso, R Ramonda, A Del Puente, L Cantarini, MA Darda, ...
Immunologic research 61 (1-2), 147-153, 2015
JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis
U Fiocco, B Accordi, V Martini, F Oliviero, M Facco, A Cabrelle, L Piva, ...
Immunologic research 58 (1), 61-69, 2014
Key facts and hot spots on tumor necrosis factor receptor‐associated periodic syndrome
D Rigante, G Lopalco, A Vitale, OM Lucherini, C De Clemente, F Caso, ...
Clinical rheumatology 33 (9), 1197-1207, 2014
The system can't perform the operation now. Try again later.
Articles 1–20